Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BTCY Biotricity	$0.54 -5.3%	$0.45	$0.19 ▼ $0.83	$13.45M	1.12	38,059 shs	19,072 shs
IINN Inspira Technologies OXY B.H.N.	$1.15 -2.5%	$1.21	$0.40 ▼ $1.65	$14.51M	2.3	1.02 million shs	435,025 shs
NXL Nexalin Technology	$0.96 +4.2%	$0.98	$0.59 ▼ $4.49	$16.66M	3.69	497,991 shs	378,161 shs
VERO Venus Concept	$2.21 -4.3%	$2.48	$2.10 ▼ $14.50	$3.15M	0.12	992,538 shs	38,971 shs

Beginner's Guide To Retirement Stocks

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BTCY Biotricity	-4.73%	+18.75%	+52.00%	+3.64%	+46.15%
IINN Inspira Technologies OXY B.H.N.	+1.72%	-5.60%	-6.35%	+99.97%	+5.36%
NXL Nexalin Technology	+13.31%	+25.73%	-14.22%	-23.46%	-1.31%
VERO Venus Concept	+1.32%	-4.94%	-5.33%	0.00%	-63.69%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BTCY Biotricity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
IINN Inspira Technologies OXY B.H.N.	3.1333 of 5 stars	3.5	5.0	0.0	0.0	3.2	1.7	0.0
NXL Nexalin Technology	3.0272 of 5 stars	3.5	5.0	0.0	0.0	2.8	1.7	0.0
VERO Venus Concept	0.6519 of 5 stars	0.0	2.0	0.0	0.0	2.1	3.3	0.0

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BTCY Biotricity	2.00	Hold	N/A	N/A
IINN Inspira Technologies OXY B.H.N.	3.00	Buy	$2.00	73.91% Upside
NXL Nexalin Technology	3.00	Buy	$5.00	427.98% Upside
VERO Venus Concept	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest VERO, NXL, IINN, and BTCY Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
6/2/2025	IINN Inspira Technologies OXY B.H.N.	Litchfield Hills Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy
6/2/2025	IINN Inspira Technologies OXY B.H.N.	Litchfield Hills Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy	$2.00

(Data available from 8/29/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BTCY Biotricity	$12.06M	1.12	N/A	N/A	($1.30) per share	-0.42
IINN Inspira Technologies OXY B.H.N.	N/A	N/A	N/A	N/A	$0.34 per share	N/A
NXL Nexalin Technology	$170K	97.04	N/A	N/A	$0.34 per share	2.79
VERO Venus Concept	$60.11M	0.05	N/A	N/A	$1.95 per share	1.14

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BTCY Biotricity	-$14.09M	-$0.21	N/A	∞	N/A	-80.42%	N/A	-188.47%	11/13/2025 (Estimated)
IINN Inspira Technologies OXY B.H.N.	-$11.05M	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
NXL Nexalin Technology	-$7.61M	-$0.76	N/A	∞	N/A	-5,057.14%	-209.20%	-186.87%	N/A
VERO Venus Concept	-$47M	-$50.78	N/A	∞	N/A	-68.77%	-871.77%	-61.92%	11/13/2025 (Estimated)

Latest VERO, NXL, IINN, and BTCY Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
8/14/2025	Q2 2025	VERO Venus Concept	-$9.72	-$8.03	+$1.69	-$8.03	$14.01 million	$15.69 million
8/6/2025	Q2 2025	NXL Nexalin Technology	-$0.14	-$0.10	+$0.04	-$0.10	$0.04 million	$0.07 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BTCY Biotricity	N/A	N/A	N/A	N/A	N/A
IINN Inspira Technologies OXY B.H.N.	N/A	N/A	N/A	N/A	N/A
NXL Nexalin Technology	N/A	N/A	N/A	N/A	N/A
VERO Venus Concept	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BTCY Biotricity	N/A	0.23	0.10
IINN Inspira Technologies OXY B.H.N.	0.09	2.02	1.89
NXL Nexalin Technology	N/A	10.43	10.14
VERO Venus Concept	5.72	1.10	0.71

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BTCY Biotricity	3.89%
IINN Inspira Technologies OXY B.H.N.	12.72%
NXL Nexalin Technology	0.65%
VERO Venus Concept	87.41%

Insider Ownership

Company	Insider Ownership
BTCY Biotricity	10.10%
IINN Inspira Technologies OXY B.H.N.	29.40%
NXL Nexalin Technology	25.26%
VERO Venus Concept	28.04%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BTCY Biotricity	40	24.91 million	22.08 million	Optionable
IINN Inspira Technologies OXY B.H.N.	20	12.62 million	8.91 million	Not Optionable
NXL Nexalin Technology	3	17.42 million	13.02 million	Not Optionable
VERO Venus Concept	410	1.42 million	1.03 million	Not Optionable

VERO, NXL, IINN, and BTCY Headlines

Recent News About These Companies

Venus Concept Secures $2M Loan for Operations

August 26 at 8:10 AM | tipranks.com

Analysts Conflicted on These Healthcare Names: Venus Concept (VERO) and TuHURA Biosciences (HURA)

August 22, 2025 | theglobeandmail.com

Venus Concept Inc. (NASDAQ:VERO) Q2 2025 Earnings Call Transcript

August 16, 2025 | msn.com

Venus Concept Reports Q2 2025 Financial Results

August 15, 2025 | msn.com

Venus Concept Inc. (VERO) Q2 2025 Earnings Call Transcript

August 14, 2025 | seekingalpha.com

Venus Concept Amends Loan Agreements for Financial Relief

August 14, 2025 | theglobeandmail.com

Venus Concept Announces Second Quarter 2025 Financial Results

August 14, 2025 | globenewswire.com

Venus Concept to Release Second Quarter of Fiscal Year 2025 Financial Results on August 14, 2025

July 16, 2025 | globenewswire.com

Venus Concept Inc. to Release Q2 Fiscal 2025 Financial Results on August 14, 2025, with Conference Call Details

July 16, 2025 | quiverquant.comQ

VERO - Venus Concept Inc Financials - Morningstar

July 8, 2025 | morningstar.comM

Venus Concept Executes Debt-to-Equity Exchange Agreement

July 1, 2025 | tipranks.com

Venus Concept Announces $6.5 Million Debt-to-Equity Exchange Transaction

July 1, 2025 | globenewswire.com

Venus Concept Inc News (VERO) - Investing.com

June 26, 2025 | investing.com

Venus Concept Stock Climbs After Stock Offering Closes

June 9, 2025 | marketwatch.com

Venus Concept Inc. Closes Registered Direct Offering and Private Placement Raising Approximately $1.15 Million

June 9, 2025 | quiverquant.comQ

Venus Concept Announces Closing of Up To $3.45 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

June 9, 2025 | globenewswire.com

Venus Concept To Sell Hair Business To Meta Healthcare In $20M All-Cash Deal

June 8, 2025 | nasdaq.com

Venus Concept prices $3.45M in direct offering, warrants; shares up over 29%

June 7, 2025 | msn.com

Venus Concept Stock Is Soaring On Friday - Here's Why

June 7, 2025 | aol.comA

Venus Concept Sells Hair Business to Meta Healthcare

June 6, 2025 | tipranks.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

VERO, NXL, IINN, and BTCY Company Descriptions

Biotricity NASDAQ:BTCY

$0.54 -0.03 (-5.26%)

As of 03:34 PM Eastern

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.

Inspira Technologies OXY B.H.N. NASDAQ:IINN

$1.15 -0.03 (-2.54%)

Closing price 04:00 PM Eastern

Extended Trading

$1.13 -0.02 (-1.74%)

As of 05:55 PM Eastern

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Inspira Technologies Oxy B.H.N. Ltd. was incorporated in 2018 and is headquartered in Ra'annana, Israel.

Nexalin Technology NASDAQ:NXL

$0.96 +0.04 (+4.19%)

Closing price 03:59 PM Eastern

Extended Trading

$0.93 -0.03 (-2.65%)

As of 05:50 PM Eastern

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company designs and develops Generation 2 and Generation 3, that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, alzheimer's disease, and dementia. It also licenses and sells Nexalin Device, a non-invasive and undetectable to the human body that can provide relief to its afflicted with mental health issues. The company is based in Houston, Texas.

Venus Concept NASDAQ:VERO

$2.21 -0.10 (-4.33%)

As of 04:00 PM Eastern

Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen, back, thights, and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles; and AI.ME an interactive, image-guided, and computer assisted system for fractional skin resurfacing. The company is headquartered in Toronto, Canada.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time